Deon J. Venter

11.6k citations

115 papers · 6.4k indexed · h-index 43

Impact in

Genetics top 0.5%
- BRCA gene mutations in cancer
- Genomic variations and chromosomal abnormalities
- Mesenchymal stem cell research
- Estrogen and related hormone effects
Cancer Research top 2%
- Cancer Genomics and Diagnostics

Papers in

Genetics 44
- BRCA gene mutations in cancer 22
- Genomic variations and chromosomal abnormalities 8
- Genetics and Neurodevelopmental Disorders 7
- Chronic Lymphocytic Leukemia Research 6
Pathology and Forensic Medicine 20
- Genetic factors in colorectal cancer 12
- Lymphoma Diagnosis and Treatment 7

Co-authors: Melissa C. Southey Jane E. Armes Graham G. Giles John L. Hopper Gillian S. Dite Margaret McCredie Gareth Price David D.L. Bowtell
Journals: Pathology (7 papers)Human Molecular Genetics (6 papers)JNCI Journal of the National Cancer Institute (3 papers)Critical Care (3 papers)Genes Chromosomes and Cancer (3 papers)
Partner nations: Australia United States New Zealand

In The Last Decade

Deon J. Venter

115 papers receiving 6.2k citations

Peers

Countries citing papers authored by Deon J. Venter

Since Specialization

Citations

This map shows the geographic impact of Deon J. Venter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deon J. Venter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deon J. Venter more than expected).

Fields of papers citing papers by Deon J. Venter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deon J. Venter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deon J. Venter. The network helps show where Deon J. Venter may publish in the future.

Co-authors

The 25 scholars most cited alongside Deon J. Venter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deon J. Venter Line = papers co-authored together Deon J. Venter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Artificial intelligence-driven biomedical genomics Knowledge-Based Systems ·Ng. Rupa Devi -, Mengjia Wu, I. A. Coulson, J.H. Kim, Yi Zhang, Qian Zhang, Bijan Mehdizadeh, A. A. Schaerer, Deon J. Venter, Guangquan Zhang, Jie Lü	2023	24
2	Functional Analysis of Genetic Variation in the SECIS Element of Thyroid Hormone Activating Type 2 Deiodinase The Journal of Clinical Endocrinology & Metabolism ·Chantal Zevenbergen, Stefan Groeneweg, Sigrid Swagemakers, Arthur P.H. de Jong, Ángel Emigdio Lagarda Lagarda, Srinivas Kommana, W Klootwijk, Marco Medici, Yolanda B. de Rijke, Marcel E. Meima, P. Reed Larsen, Laurent Chavatte, Deon J. Venter, Robin P. Peeters, Peter J. van der Spek, W. Edward Visser	2018	3
3	A point mutation in the pre-ZRS disrupts sonic hedgehog expression in the limb bud and results in triphalangeal thumb–polysyndactyly syndrome Genetics in Medicine ·Alexia Gomart, Yulong Ge, Rivka Sukenik‐Halevy, Hannie Douben, Awosika Olawoyin, Deon J. Venter, Priya Ranjan Saha, Sigrid Swagemakers, Steven E.R. Hovius, Christianne A. van Nieuwenhoven, Robert‐Jan H. Galjaard, Peter J. van der Spek, Nadav Ahituv, Annelies de Klein	2018	22
4	MALDI-TOF MS meets WGS in a VRE outbreak investigation European Journal of Clinical Microbiology & Infectious Diseases ·Sanmarié Schlebusch, Gareth Price, Priya Ranjan Saha, 昂松元, Liam D. H. Elbourne, Paul Griffin, Deon J. Venter, Slade O. Jensen, Sebastiaan J. van Hal	2016	16
5	Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non–Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial Annals of the American Thoracic Society ·Lucy Burr, Geraint B. Rogers, Alice C.–H. Chen, Brett R. Hamilton, 毅大江, Steven Taylor, Deon J. Venter, Simon Bowler, G M Kobayashi, Michael A. McGuckin	2016	26
6	High resolution spatial mapping of brominated pyrrole-2-aminoimidazole alkaloids distributions in the marine sponge Stylissa flabellata via MALDI-mass spectrometry imaging Molecular BioSystems ·Jennifer Yarnold, Brett R. Hamilton, David T. Welsh, 毅大江, Deon J. Venter, Anthony R. Carroll	2012	24
7	Differential diagnosis of serous papillary carcinoma of the gynaecological tract and basal breast carcinoma: an immunohistochemical approach Pathology ·Jane E. Armes, C. Lionte, Rohan Lourie, Deon J. Venter, Gareth Price	2010	3
8	Comparison of Human Placenta- and Bone Marrow–Derived Multipotent Mesenchymal Stem Cells Stem Cells and Development ·M. Tantama, Gary Brooke, Wan-Yin Qi, Gareth Price, Rebecca Pelekanos, Tony Rossetti, Sarah Tracey, Deon J. Venter, Heyuan Yao, Kristen Gilshenan, Kerry Atkinson	2008	298
9	Abnormalities of the RB1 Pathway in Ovarian Serous Papillary Carcinoma as Determined by Overexpression of the p16(INK4A) Protein International Journal of Gynecological Pathology ·Jane E. Armes, Rohan Lourie, Melanie de Silva, Dengpei Ouyang, Alison Boyd, Beena Kumar, Gareth Price, Simon Hyde, David G. Allen, Peter Grant, Deon J. Venter	2005	46
10	027. Mapping novel breast cancer susceptibility genes by linkage analysis of Australian multiple case kindreds Reproduction Fertility and Development ·Graham J. Mann, Gulietta M. Pupo, Beth Newman, Deon J. Venter, John L. Hopper, Georgia Chenevix‐Trench, kConFab	2004	1
11	Detailed gene copy number and RNA expression analysis of the 17q12–23 region in primary breast cancers Genes Chromosomes and Cancer ·Simon N. Willis, Anne‐Marie Hutchins, Fleur Hammet, A.M. Tyrell, Wee Kheng Soo, M Timio, Peter J. van der Spek, Michael A. Henderson, Kurt Gish, Deon J. Venter, Jane E. Armes	2003	22
12	After hMSH2 and hMLH1—what next? Analysis of three‐generational, population‐based, early‐onset colorectal cancer families International Journal of Cancer ·Mark A. Jenkins, Laura Baglietto, Gillian S. Dite, Damien John Jolley, Melissa C. Southey, Simón Pedro Izcara Palacios, Leeanne J. Mead, David John, Finlay Macrae, D. Timothy Bishop, Deon J. Venter, Graham G. Giles, John L. Hopper	2002	31
13	The BRCA2 372 HH Genotype Is Associated with Risk of Breast Cancer in Australian Women Under Age 60 Years 1 QUT ePrints (Queensland University of Technology) ·Amanda B. Spurdle, John L. Hopper, Xiaohong Chen, Gillian S. Dite, Jisheng Cui, Margaret McCredie, Graham G. Giles, Tobias Bulang, Deon J. Venter, Beth Newman, Melissa C. Southey, Georgia Chenevix‐Trench	2002	8
14	Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. PubMed ·Toula Bouras, Melissa C. Southey, Deon J. Venter	2001	161
15	Gene Targeting of Desrt, a Novel ARID Class DNA-Binding Protein, Causes Growth Retardation and Abnormal Development of Reproductive Organs Genome Research ·Mireille H. Lahoud, Sika Ristevski, Deon J. Venter, Lars S. Jermiin, Ivan Bertoncello, Silva Zavarsek, 孟解放, John Drago, David de Kretser, Paul J. Hertzog, Ismail Kola	2001	87
16	Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients International Journal of Radiation OncologyBiologyPhysics ·Diane Severin, Trevor Leong, Nicole Crimi, Hany Elsaleh, Lester Peters, Deon J. Venter, Melissa C. Southey, Michael J. McKay	2001	56
17	Paraffin Section Immunotyping of Leukaemias British Journal of Haematology ·Surender Juneja, L. Trute, David Westerman, Deon J. Venter, J.F. Seymour, H. Miles Prince	2000	2
18	Hypereosinophilic syndrome or chronic eosinophilic leukemia: report of a case with a lytic bone lesion Leukemia ·Surender Juneja, Josephine Stewart, A L McKenzie, Deon J. Venter, Henry Januszewicz	1997	4
19	Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene Human Molecular Genetics ·Lois M. Mulligan, Charis Eng, K. Mejnoun, Stanislas Lyonnet, Deborah J. Marsh, V.J. Hyland, Bruce G. Robinson, Andrea Frilling, Ryszard Wiśniewski, 伊沢利典, Deon J. Venter, Arnold Münnich, Bruce A.J. Ponder	1994	183
20	Production and characterization of monoclonal antibodies to the c-erbB-2 proto-oncogene protein using a synthetic peptide immunogen Biochemical Society Transactions ·Nadia L. Tuzi, Deon J. Venter, C. Sch., Christopher Dean, William J. Gullick	1988	2

About Deon J. Venter

Deon J. Venter is a scholar working on Genetics, Pathology and Forensic Medicine, Cancer Research, Genetics and Molecular Biology, having authored 115 papers that have together received 6.4k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (22 papers), Genetic factors in colorectal cancer (12 papers), Cancer Genomics and Diagnostics (10 papers), DNA Repair Mechanisms (8 papers), Genomic variations and chromosomal abnormalities (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Genetics and Neurodevelopmental Disorders (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Genetics (2.0k citations), Cancer Research (994 citations), Oncology (1.2k citations), Molecular Biology (3.0k citations) and Genetics (392 citations). Deon J. Venter has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include Melissa C. Southey, Jane E. Armes, Graham G. Giles, John L. Hopper, Gillian S. Dite, Margaret McCredie, Gareth Price, David D.L. Bowtell, Roger R. Reddel and Toula Bouras. Their work appears in journals such as Pathology, Human Molecular Genetics, JNCI Journal of the National Cancer Institute, Critical Care and Genes Chromosomes and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact